Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022454

« Back to Dashboard
NDA 022454 describes DATSCAN, which is a drug marketed by Ge Hlthcare Inc and is included in one NDA. It is available from one supplier. Additional details are available on the DATSCAN profile page.

The generic ingredient in DATSCAN is ioflupane i-123. One supplier is listed for this compound. Additional details are available on the ioflupane i-123 profile page.

Summary for NDA: 022454


Pharmacology for NDA: 022454

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 022454

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ioflupane i-123
SOLUTION;INTRAVENOUS 022454 NDA Medi-Physics Inc. dba GE Healthcare. 17156-210 17156-210-01 1 VIAL, GLASS in 1 CONTAINER (17156-210-01) > 2.5 mL in 1 VIAL, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength5mCi/2.5ML (2mCi/ML)
Approval Date:Jan 14, 2011TE:RLD:Yes

Expired Orange Book Patents for NDA: 022454

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Hlthcare Inc
ioflupane i-123
SOLUTION;INTRAVENOUS022454-001Jan 14, 2011► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
US Army
Chinese Patent Office
Express Scripts
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus